1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SAB BIOTHERAPEUTICS INC
SAB Biotherapeutics Inc XNAS: SABS
2.70 0.13 (5.06%)
81.6M

XNAS 21 Jul, 2025 5:30 PM (EDT)

SAB Biotherapeutics Inc quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents